Vectorious Medical Technologies Announces World’s First In-Heart Microcomputer for Left Atrial Pressure Monitoring
Feb 4, 2019Tel-Aviv, Israel (4 February, 2019) – Vectorious Medical Technologies, a medical device company enabling optimal management for heart failure patients, today announced the initiation of the VECTOR-HF First-in-Human (FIH) clinical trial, and the successful first ‘in-human’ implantation of the V-LAPTM monitoring device.